Impact of Hepatitis C Treatment as Prevention for People Who Inject Drugs is sensitive to contact network structure

Treatment as Prevention (TasP) using directly-acting antivirals has been advocated for Hepatitis C Virus (HCV) in people who inject drugs (PWID), but treatment is expensive and TasP’s effectiveness is uncertain. Previous modelling has assumed a homogeneously-mixed population or a static network lack...

Descripción completa

Detalles Bibliográficos
Autores principales: Metzig, Cornelia, Surey, Julian, Francis, Marie, Conneely, Jim, Abubakar, Ibrahim, White, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431870/
https://www.ncbi.nlm.nih.gov/pubmed/28500290
http://dx.doi.org/10.1038/s41598-017-01862-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431870/
https://www.ncbi.nlm.nih.gov/pubmed/28500290
http://dx.doi.org/10.1038/s41598-017-01862-6

Ejemplares similares